跳转至内容
Merck
CN

860701P

Avanti

C17:0 Gb2

Avanti Research - A Croda Brand

别名:

C17:0 Galabiosylceramide

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C47H89NO13
化学文摘社编号:
分子量:
876.21
MDL number:
NACRES:
NA.28
UNSPSC Code:
12352211
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

C17:0 Gb2, powder

assay

99% (TLC)

form

powder

packaging

package of 1 × 500 μg (860701P-500UG)

manufacturer/tradename

Avanti Research - A Croda Brand

lipid type

sphingolipids

shipped in

dry ice

storage temp.

−20°C

General description

Galabiosylceramide (Ga2cer) is a glycolipid and is produced in the luminal leaflet of the Golgi apparatus.

Biochem/physiol Actions

Galabiosylceramide (Ga2cer) is accumulated in larger amounts in Fabry′s disease.

Packaging

5 mL Clear Glass Sealed Ampule (860701P-500UG)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

存储类别

11 - Combustible Solids

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

涉药品监管产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Topology of sphingolipid galactosyltransferases in ER and Golgi: trans bilayer movement of mono hexosyl sphingolipids is required for higher glycosphingolipid biosynthesis.
Burger KN, et al.
The Journal of Cell Biology, 133(1), 15-28 (1996)
Accumulation of glycosphingolipids in spinal and sympathetic ganglia of a symptomatic heterozygote of Fabry's disease
Hozumi I, et al.
Journal of the Neurological Sciences, 90(3), 273-280 (1989)

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持